Enhanced estrogen-induced proliferation in obese rat endometrium.

[1]  H. Kuramoto,et al.  Stimulatory effect of estrogen on the growth of endometrial cancer cells is regulated by cell-cycle regulators , 2007, The Journal of Steroid Biochemistry and Molecular Biology.

[2]  Tomomi Sato,et al.  Comparison of estrogen responsive genes in the mouse uterus, vagina and mammary gland. , 2007, The Journal of veterinary medical science.

[3]  J. Kench,et al.  Secreted frizzled‐related protein 4 inhibits proliferation and metastatic potential in prostate cancer , 2007, The Prostate.

[4]  P. Viganò,et al.  PI3K/Akt and ERK1/2 signalling pathways are involved in endometrial cell migration induced by 17beta-estradiol and growth factors. , 2007, Molecular human reproduction.

[5]  J. Morissette,et al.  Temporal analysis of E2 transcriptional induction of PTP and MKP and downregulation of IGF-I pathway key components in the mouse uterus. , 2007, Physiological genomics.

[6]  P. Goodfellow,et al.  Body mass index: relationship to clinical, pathologic and features of microsatellite instability in endometrial cancer. , 2007, Gynecologic oncology.

[7]  C. Mantzoros,et al.  Diabetes and Risk of Endometrial Cancer: A Population-Based Prospective Cohort Study , 2007, Cancer Epidemiology Biomarkers & Prevention.

[8]  E. Moran,et al.  Relationship between E1A binding to cellular proteins, c-myc activation and S-phase induction , 2007, Oncogene.

[9]  J. Kench,et al.  Secreted frizzled-related protein 4 inhibits proliferation and metastatic potential in prostate cancer. , 2006, The Prostate.

[10]  F. Kayaselçuk,et al.  Expression of survivin, PTEN and p27 in normal, hyperplastic, and carcinomatous endometrium , 2006, International Journal of Gynecologic Cancer.

[11]  P. Dollé,et al.  Regulation of expression of the retinoic acid-synthesising enzymes retinaldehyde dehydrogenases in the uteri of ovariectomised mice after treatment with oestrogen, gestagen and their combination. , 2006, Reproduction, fertility, and development.

[12]  R. Seger,et al.  The extracellular signal-regulated kinase: Multiple substrates regulate diverse cellular functions , 2006, Growth factors.

[13]  M. Al-Dhaheri,et al.  Selenium disrupts estrogen receptor α signaling and potentiates tamoxifen antagonism in endometrial cancer cells and tamoxifen-resistant breast cancer cells , 2005, Molecular Cancer Therapeutics.

[14]  J. Davie,et al.  The Ras-MAPK signal transduction pathway, cancer and chromatin remodeling. , 2005, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[15]  K. Zatloukal,et al.  Inverse correlation of secreted frizzled‐related protein 4 and β‐catenin expression in endometrial stromal sarcomas , 2004, The Journal of pathology.

[16]  G. Shulman,et al.  Effects of Rexinoids on Glucose Transport and Insulin-mediated Signaling in Skeletal Muscles of Diabetic (db/db) Mice* , 2004, Journal of Biological Chemistry.

[17]  G. Stancel,et al.  Coordinate regulation of the production and signaling of retinoic acid by estrogen in the human endometrium. , 2003, The Journal of clinical endocrinology and metabolism.

[18]  Y. Ouchi,et al.  Differential expression of secreted frizzled-related protein 4 in decidual cells during pregnancy. , 2002, Journal of molecular endocrinology.

[19]  L. Altucci,et al.  Cell type-specific induction of cyclin D and cyclin-dependent kinase inhibitor p27 kip1 expression by estrogen in rat endometrium , 2001, The Journal of Steroid Biochemistry and Molecular Biology.

[20]  R. Hoover,et al.  Case-control study of endogenous steroid hormones and endometrial cancer. , 1996, Journal of the National Cancer Institute.

[21]  F. Zindy,et al.  Overexpression of human cyclin A advances entry into S phase. , 1995, Oncogene.

[22]  C. Chuang,et al.  Functional divergence of the MAP kinase pathway ERK1 and ERK2 activate specific transcription factors , 1994, FEBS letters.

[23]  H. Kuramoto,et al.  Immunocytochemical determination of estrogen and progesterone receptors in human endometrial adenocarcinoma cells (ishikawa cells) , 1992, The Journal of Steroid Biochemistry and Molecular Biology.

[24]  R. Bergström,et al.  Serum estrogens and androgens in women with endometrial carcinoma. , 1986, Gynecologic oncology.

[25]  G. Bray.  The Zucker-fatty rat: a review. , 1977, Federation proceedings.

[26]  H. Antoniades,et al.  Insulin and obesity in the Zucker genetically obese rat "fatty". , 1972, Endocrinology.

[27]  D. Schottenfeld.  Epidemiology of endometrial neoplasia , 1995, Journal of cellular biochemistry. Supplement.

[28]  Eric Wickstrom,et al.  A c-myc antisense oligodeoxynucleotide inhibits entry into S phase but not progress from G0 to G1 , 1987, Nature.

[29]  H. Kuramoto,et al.  Responses to estradiol in a human endometrial adenocarcinoma cell line (Ishikawa). , 1986, Journal of steroid biochemistry.